# Effects of Aromatase Inhibition Versus Testosterone in Older Men With Low Testosterone: Randomized-Controlled Trial.

> **NCT00104572** · PHASE2 · COMPLETED · sponsor: **National Institute on Aging (NIA)** · enrollment: 44 (actual)

## Conditions studied

- Hypogonadism
- Diabetes
- Sarcopenia
- Osteoporosis
- Depression

## Interventions

- **DRUG:** Androgel (Testosterone Gel)
- **DRUG:** Anastrozole (Aromatase Inhibitor)
- **DRUG:** Placebo tablet
- **DRUG:** Placebo gel
- **DIETARY_SUPPLEMENT:** Calcium Cardone 500mg with vitamin D 400 IU

## Key facts

- **NCT ID:** NCT00104572
- **Lead sponsor:** National Institute on Aging (NIA)
- **Sponsor class:** NIH
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2004-03
- **Primary completion:** 2013-12
- **Final completion:** 2015-01
- **Target enrollment:** 44 (ACTUAL)
- **Last updated:** 2018-11-06


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00104572

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00104572, "Effects of Aromatase Inhibition Versus Testosterone in Older Men With Low Testosterone: Randomized-Controlled Trial.". Retrieved via AI Analytics 2026-05-24 from https://api.ai-analytics.org/clinical/NCT00104572. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*